Olive 'over-promises' and 'under-delivers' on AI capabilities
A US start-up that had promised to "turbocharge" healthcare AI was accused of misleading marketing and poor ethics. Olive AI laid off 450 employees in a move said by CEO Sean Lane to have been caused by the company's 'fast-paced growth and lack of focus'. But the claim was seen as contradicting Axios i nterviews with f ormer and current employees and health tech executives suggesting the company regularly o ver-hyped its capabilities and under-delivered, generating 'only a fraction of the savings it promises.' Olive had been through various incarnations since it was founded in 2012, and was at one time valued at USD 4 billion. But it was regularly dogged by questions about the efficacy of its software and the integrity of its marketing and leadership. ➕ Oc tober 2023. Olive announced it had sold off pieces of its business to healthcare companies Waystar and Humata Health, and would be closing. System 🤖 Olive AI 🔗 Operator: WPP/ AKQA; Circulo Health ; GuideWell; TriHealth Developer: Olive AI Country: USA Sector: Health Purpose: Automate healthcare services Technology: Robotic Process Automation (RPA); Machine learning Issue: Effectiveness/value; Transparency
- Date it happened
- 2022-07-01
- Organisation involved
- GuideWell; WPP/AKQA; TriHealth; Circulo Health
This incident was imported from AIAAIC and is used under CC BY-SA 4.0. Our additions to it — the structured fields, the translation, the checks against other reports — are published under the same licence.
This is a record of what was reported, not a finding that anyone broke the law. If it names your organisation and you believe it is wrong, the corrections process is free and open to everyone.